Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3085 (117th)

ENACT Act of 2021

referredUnited States· United States Congress· EN

Introduced

11 May 2021

Last action

12 May 2021 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Sen. Blunt Rochester, Lisa [D-DE], Rep. Herrera Beutler, Jaime [R-WA-3], Sen. Curtis, John R. [R-UT], Rep. Smith, Christopher H. [R-NJ-4], Rep. Waters, Maxine [D-CA-43], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Cohen, Steve [D-TN-9], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Swalwell, Eric [D-CA-15], Rep. Castro, Joaquin [D-TX-20], Rep. Demings, Val Butler [D-FL-10], Rep. Amodei, Mark E. [R-NV-2], Rep. Jones, Mondaire [D-NY-17], Rep. Ross, Deborah K. [D-NC-2], Rep. Suozzi, Thomas R. [D-NY-3], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Khanna, Ro [D-CA-17], Rep. Soto, Darren [D-FL-9], Rep. Rogers, Mike D. [R-AL-3], Sen. Kim, Andy [D-NJ], Rep. Higgins, Brian [D-NY-26], Rep. Manning, Kathy E. [D-NC-6], Sen. Gallego, Ruben [D-AZ], Rep. Case, Ed [D-HI-1], Rep. DeSaulnier, Mark [D-CA-10], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Katko, John [R-NY-24], Rep. Lee, Barbara [D-CA-12], Rep. Wild, Susan [D-PA-7], Rep. Bacon, Don [R-NE-2], Rep. Duncan, Jeff [R-SC-3], Rep. Cole, Tom [R-OK-4], Rep. Valadao, David G. [R-CA-22], Rep. Newhouse, Dan [R-WA-4], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Garbarino, Andrew R. [R-NY-2], Rep. Smucker, Lloyd [R-PA-11], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Tonko, Paul [D-NY-20], Rep. Murphy, Stephanie N. [D-FL-7], Rep. Yarmuth, John A. [D-KY-3], Rep. Porter, Katie [D-CA-47], Rep. Lynch, Stephen F. [D-MA-8], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Kildee, Daniel T. [D-MI-5], Colin Allred, Rep. Lawson, Al, Jr. [D-FL-5], Rep. Axne, Cynthia [D-IA-3]

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Summary

Equity in Neuroscience and Alzheimer's Clinical Trials Act of 2021 or the ENACT Act of 2021 This bill sets out activities and requirements to increase the participation of underrepresented populations in research and clinical trials for Alzheimer's disease and related dementias. Specifically, the National Institute on Aging (NIA) must establish and provide technical assistance to Alzheimer's research centers located in areas with higher concentrations of minority groups. These centers must establish diagnostic and treatment clinics designed to serve minority, rural, and other underserved populations; operate clinical trials; and carry out public outreach to encourage members of minority populations to participate in clinical trials and research. Additionally, the NIA must disseminate information to members of minority populations about participating in clinical trials and take other actions to enhance diversity with respect to the Alzheimer's research that it conducts or supports. The bill also directs the NIA to increase diversity among Alzheimer's researchers by encouraging the participation of individuals who are from groups that are underrepresented in clinical, behavioral, and social sciences.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  2. 11 May 2021

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  3. 11 May 2021

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 12 May 2021

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 11 May 2021

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 11 May 2021

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 11 May 2021

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 140 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.